Author Question: A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a ... (Read 101 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a (Pegasys), ribavirin (Ribasphere), and boceprevir (Victrelis). The patient tells the nurse that his wife is pregnant. What will the nurse tell him?
 
  a. Boceprevir is contraindicated in males whose partners are pregnant.
  b. He should use a barrier contraceptive when having sex.
  c. He should use dual drug therapy with pegylated interferon alfa and ribavirin only.
  d. This combination drug therapy is safe for him to use.

Question 2

A patient has a positive test for hepatitis C and is admitted to the hospital. The admission laboratory tests reveal a normal ALT, and a liver biopsy is negative for hepatic fibrosis and inflammation. The nurse will prepare this patient for:
 
  a. dual therapy with pegylated interferon alfa and ribavirin.
  b. no medication therapy at this time.
  c. pegylated interferon alfa only until ALT levels are elevated.
  d. triple drug therapy with pegylated interferon alfa, ribavirin, and boceprevir.



Jossy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: A
The triple combination is dangerous for pregnant women whose partners are using it, so it is contraindicated for any man whose partner is pregnant. Barrier contraceptives should be used by couples when either partner is taking the triple combination therapy to prevent pregnancy. Ribavirin is teratogenic and is not safe when a partner is pregnant. This combination is not safe for pregnant women whose partners are taking these drugs.

Answer to Question 2

ANS: B
Current recommendations are that treatment is used only for patients with HCV viremia, persistent elevation of ALT, and evidence of hepatic fibrosis and inflammation upon liver biopsy. Dual therapy has been the regimen of choice for patients with the above symptoms, but the addition of a protease inhibitor has been shown to improve outcomes. It is not correct to give pegylated interferon alfa until ALT levels are elevated. Triple drug therapy is used for patients with the above symptoms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Both answers were spot on, thank you once again



Jossy

  • Sr. Member
  • ****
  • Posts: 336

 

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

For a complete list of videos, visit our video library